BACKGROUND: Many patients with intestinal failure require intestinal transplantation (ITx) to survive. Acute cellular rejection poses a challenge in ITx because its biologic components are incompletely understood. New methodologies for its integrative and longitudinal analysis are needed. METHODS: In this study, we characterized episodes of acute cellular rejection in ITx recipients using a noninvasive proteomic analysis. Ostomy effluent was obtained from all patients undergoing ITx at University of California, Los Angeles from July 2008 to September 2009 during surveillance endoscopies in the first 8 weeks post-ITx. Effluent was analyzed using 17-plex Luminex technology and matrix-assisted laser desorption/ionization proteomics. RESULTS: Of 56 ostomy effluent samples from 17 ITx recipients, 14% developed biopsy-proven rejection at a median of 25 days post-ITx. Six had mild rejection, two were indeterminate for rejection, and no graft loss was seen in the first 3 months posttransplantation. Effluent levels of five innate immune cytokines were elevated in the posttransplantation phase: granulocyte colony-stimulating factor, interleukin-8, tissue necrosis factor-α, interleukin-1β, and interferon-γ. Proteomic analysis revealed 17 protein features differentially seen in rejection, two identified as human neutrophil peptide 1 and 2. This was confirmed by the presence of human neutrophil peptide-positive lamina propria neutrophils in biopsy tissue samples. CONCLUSIONS: Proteomic and cytokine analysis of ostomy effluents suggests an early and unappreciated role of innate immune activation during rejection.
BACKGROUND: Many patients with intestinal failure require intestinal transplantation (ITx) to survive. Acute cellular rejection poses a challenge in ITx because its biologic components are incompletely understood. New methodologies for its integrative and longitudinal analysis are needed. METHODS: In this study, we characterized episodes of acute cellular rejection in ITx recipients using a noninvasive proteomic analysis. Ostomy effluent was obtained from all patients undergoing ITx at University of California, Los Angeles from July 2008 to September 2009 during surveillance endoscopies in the first 8 weeks post-ITx. Effluent was analyzed using 17-plex Luminex technology and matrix-assisted laser desorption/ionization proteomics. RESULTS: Of 56 ostomy effluent samples from 17 ITx recipients, 14% developed biopsy-proven rejection at a median of 25 days post-ITx. Six had mild rejection, two were indeterminate for rejection, and no graft loss was seen in the first 3 months posttransplantation. Effluent levels of five innate immune cytokines were elevated in the posttransplantation phase: granulocyte colony-stimulating factor, interleukin-8, tissue necrosis factor-α, interleukin-1β, and interferon-γ. Proteomic analysis revealed 17 protein features differentially seen in rejection, two identified as human neutrophil peptide 1 and 2. This was confirmed by the presence of human neutrophil peptide-positive lamina propria neutrophils in biopsy tissue samples. CONCLUSIONS: Proteomic and cytokine analysis of ostomy effluents suggests an early and unappreciated role of innate immune activation during rejection.
Authors: J Wehkamp; B Schwind; K R Herrlinger; S Baxmann; K Schmidt; M Duchrow; C Wohlschläger; A C Feller; E F Stange; K Fellermann Journal: Dig Dis Sci Date: 2002-06 Impact factor: 3.199
Authors: Marjorie-Anne R Guerra; Maura Rossetti; Zhenyu Zhang; Xinkai Zhou; Emily C Whang; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Douglas G Farmer; Elaine F Reed; Laura J Wozniak Journal: Transpl Immunol Date: 2018-09-20 Impact factor: 1.708
Authors: Debra Franck; Yeun Goo Chung; Jeannine Coburn; David L Kaplan; Carlos R Estrada; Joshua R Mauney Journal: J Tissue Eng Date: 2014-11-05 Impact factor: 7.813
Authors: Xiaoxiao Li; James LeBlanc; David Elashoff; Ian McHardy; Maomeng Tong; Bennett Roth; Andrew Ippoliti; Gildardo Barron; Dermot McGovern; Keely McDonald; Rodney Newberry; Thomas Graeber; Steve Horvath; Lee Goodglick; Jonathan Braun Journal: Cell Mol Gastroenterol Hepatol Date: 2016-05-17
Authors: Mihai Oltean; Jasmine Bagge; George Dindelegan; Diarmuid Kenny; Antonio Molinaro; Mats Hellström; Ola Nilsson; Carina Sihlbom; Anna Casselbrant; Marcela Davila; Michael Olausson Journal: Metabolites Date: 2021-12-27